Literature DB >> 29614676

Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.

Katerina A Tetzloff1, Jonathan Graff-Radford2, Peter R Martin3, Nirubol Tosakulwong3, Mary M Machulda4, Joseph R Duffy2, Heather M Clark2, Matthew L Senjem1,5, Christopher G Schwarz1, Anthony J Spychalla1, Daniel A Drubach2, Clifford R Jack1, Val J Lowe1, Keith A Josephs2, Jennifer L Whitwell1.   

Abstract

BACKGROUND: Despite common pathology, Alzheimer's disease (AD) can have multiple clinical presentations which pathological studies suggest result from differences in the regional distribution of tau pathology. Positron emission tomography (PET) ligands are now available that can detect tau proteins in vivo and hence can be used to investigate the biological mechanisms underlying atypical AD.
OBJECTIVE: To assess regional patterns of tau uptake on PET imaging in two atypical AD variants, posterior cortical atrophy (PCA) and logopenic progressive aphasia (lvPPA).
METHODS: Eighteen PCA and 19 lvPPA subjects that showed amyloid-β deposition on PET underwent tau-PET imaging with [18F]AV-1451. Group comparisons of tau uptake in PCA and lvPPA were performed using voxel-level and regional-level analyses. We also assessed the degree of lobar tau asymmetry and correlated regional tau uptake to age and performance on clinical evaluations.
RESULTS: Both syndromes showed diffuse tau uptake throughout all cortical regions, although PCA showed greater uptake in occipital regions compared to lvPPA, and lvPPA showed greater uptake in left frontal and temporal regions compared to PCA. While lvPPA showed predominant left-asymmetric tau deposition, PCA was more bilateral. Younger subjects showed greater tau uptake bilaterally in frontal and parietal lobes than older subjects, and sentence repetition, Boston naming test, simultanagnosia, and visuoperceptual function showed specific regional tau correlates.
CONCLUSION: Tau deposition is closely related to clinical presentation in atypical AD with age playing a role in determining the degree of cortical tau deposition.

Entities:  

Keywords:  Aphasia; dementia; neuroimaging; positron emission tomography

Mesh:

Substances:

Year:  2018        PMID: 29614676      PMCID: PMC6133300          DOI: 10.3233/JAD-170740

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  48 in total

1.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

2.  Anatomy of language impairments in primary progressive aphasia.

Authors:  Emily Rogalski; Derin Cobia; Theresa M Harrison; Christina Wieneke; Cynthia K Thompson; Sandra Weintraub; M-Marsel Mesulam
Journal:  J Neurosci       Date:  2011-03-02       Impact factor: 6.167

3.  Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Authors:  David T Chien; Shadfar Bahri; A Katrin Szardenings; Joseph C Walsh; Fanrong Mu; Min-Ying Su; William R Shankle; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Quantitative neurofibrillary tangle density and brain volumetric MRI analyses in Alzheimer's disease presenting as logopenic progressive aphasia.

Authors:  Keith A Josephs; Dennis W Dickson; Melissa E Murray; Matthew L Senjem; Joseph E Parisi; Ronald C Petersen; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain Lang       Date:  2013-03-28       Impact factor: 2.381

Review 5.  The logopenic variant of primary progressive aphasia.

Authors:  Maya L Henry; Maria Luisa Gorno-Tempini
Journal:  Curr Opin Neurol       Date:  2010-12       Impact factor: 5.710

6.  Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.

Authors:  Hanna Cho; Jae Yong Choi; Seung Ha Lee; Jae Hoon Lee; Young-Chul Choi; Young Hoon Ryu; Myoung Sik Lee; Chul Hyoung Lyoo
Journal:  Neurobiol Aging       Date:  2017-02-09       Impact factor: 4.673

7.  Facile Route to 2-Fluoropyridines via 2-Pyridyltrialkylammonium Salts Prepared from Pyridine N-Oxides and Application to (18)F-Labeling.

Authors:  Hui Xiong; Adam T Hoye; Kuo-Hsien Fan; Ximin Li; Jennifer Clemens; Carey L Horchler; Nathaniel C Lim; Giorgio Attardo
Journal:  Org Lett       Date:  2015-07-20       Impact factor: 6.005

8.  An empirically derived short form of the Boston naming test.

Authors:  A E Lansing; R J Ivnik; C M Cullum; C Randolph
Journal:  Arch Clin Neuropsychol       Date:  1999-08       Impact factor: 2.813

9.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

10.  The logopenic/phonological variant of primary progressive aphasia.

Authors:  M L Gorno-Tempini; S M Brambati; V Ginex; J Ogar; N F Dronkers; A Marcone; D Perani; V Garibotto; S F Cappa; B L Miller
Journal:  Neurology       Date:  2008-07-16       Impact factor: 9.910

View more
  23 in total

1.  Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease.

Authors:  Musa Gabere; Nha Trang Thu Pham; Jonathan Graff-Radford; Mary M Machulda; Joseph R Duffy; Keith A Josephs; Jennifer L Whitwell
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

2.  The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease.

Authors:  Jennifer L Whitwell; Peter Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Stephen D Weigand; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2019-03-08       Impact factor: 21.566

3.  Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.

Authors:  Irene Sintini; Jonathan Graff-Radford; Matthew L Senjem; Christopher G Schwarz; Mary M Machulda; Peter R Martin; David T Jones; Bradley F Boeve; David S Knopman; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

4.  Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.

Authors:  Irene Sintini; Christopher G Schwarz; Peter R Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Robert I Reid; Anthony J Spychalla; Daniel A Drubach; Val J Lowe; Clifford R Jack; Keith A Josephs; Jennifer L Whitwell
Journal:  Hum Brain Mapp       Date:  2018-12-13       Impact factor: 5.038

Review 5.  Recent update on the heterogeneity of the Alzheimer's disease spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-12-17       Impact factor: 3.575

6.  Case Study 1: A 55-Year-Old Woman With Progressive Cognitive, Perceptual, and Motor Impairments.

Authors:  Scott M McGinnis; Andrew M Stern; Jared K Woods; Matthew Torre; Mel B Feany; Michael B Miller; David A Silbersweig; Seth A Gale; Kirk R Daffner
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2021-11-12       Impact factor: 2.198

7.  Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles.

Authors:  Neha Atulkumar Singh; Jonathan Graff-Radford; Mary M Machulda; Christopher G Schwarz; Matthew C Baker; Rosa Rademakers; Nilufer Ertekin-Taner; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  J Neurol       Date:  2022-08-24       Impact factor: 6.682

Review 8.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

9.  Tau and Amyloid Relationships with Resting-state Functional Connectivity in Atypical Alzheimer's Disease.

Authors:  Irene Sintini; Jonathan Graff-Radford; David T Jones; Hugo Botha; Peter R Martin; Mary M Machulda; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  Cereb Cortex       Date:  2021-02-05       Impact factor: 5.357

10.  Crossed cerebellar diaschisis on 18F-FDG PET: Frequency across neurodegenerative syndromes and association with 11C-PIB and 18F-Flortaucipir.

Authors:  Karine Provost; Renaud La Joie; Amelia Strom; Leonardo Iaccarino; Lauren Edwards; Taylor J Mellinger; Julie Pham; Suzanne L Baker; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  J Cereb Blood Flow Metab       Date:  2021-03-10       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.